semaglutide from weight watchers WeightWatchers to sell Novo Nordisk's Wegovy pill after 2026 launch WeightWatchers Is Getting into Weight-Loss

- Proprietary ingredient exclusively developed by EST, currently under patent application

Patients using it as part of a supervised plan consistently report body composition changes alongside improvements in skin quality results we rarely see from single-compound interventions. This sentiment is echoed across leading peptide serum clinics in the US, UK, and Australia, where AOD 9064 is increasingly offered as part of comprehensive metabolic or aesthetic treatment plans

Tirzepatide works by engaging both GLP-1 and GIP receptors, offering a broad metabolic impact

However, results can be different for each person